- A Case Report of Three Patients with Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium kansasii
-
Koh WJ, Kwon OJ, Suh GY, Chung MP, Kim H, Lee NY, Kim TS, Lee KS, Park EM, Park YK, Bai GH
- KMID: 2318418
- Tuberc Respir Dis.
- 2003 Apr;54(4):459-466.
Mycobacterium kansasii is the second most common cause of nontuberculous mycobacterial pulmonary disease in Western countries and Japan. The clinical and radiological features of pulmonary disease caused by M. kansasii... -
- CITED
-
- Close
- SHARE
-
- Close
- Polymorphisms of HLA-DRB1 and -DQB1 Genes in Korean Patients with Pulmonary Tuberculosis
-
Park MH, Song EY, Kwon SY, Park H, Han SK, Shim YS
- KMID: 2318409
- Tuberc Respir Dis.
- 2003 Apr;54(4):367-377.
BACKGROUND: It is well known that only 10% of those infected with Mycobacterium tuberculosis actually develop clinical disease, indicating the existence of host genetic factors regulating disease expression. In this... -
- CITED
-
- Close
- SHARE
-
- Close
- Does the Layman Understand "the Whistling Sounds when Breathing out" as Real Wheezing?
-
Jang SH, Jung SH, Eom KS, Shin T, Kim CH, Bahn JW, Kim DG, Park MJ, Hyun IG, Jung KS
- KMID: 2318410
- Tuberc Respir Dis.
- 2003 Apr;54(4):378-385.
BACKGROUND: Wheezing is an important clue in the diagnosis of asthma. Previously, a Korean National asthma survey used a written questionnaire, containing the question, "Have you ever experienced a breathing... -
- CITED
-
- Close
- SHARE
-
- Close
- The Changes of Physiologic Parameters with Time in Steroid treated-Late Acute Respiratory Distress Syndrome Patients
-
Jeon IS, Suh GY, Koh WJ, Pyun YJ, Kang EH, Ham HS, Oui M, Chung MP, Kim H, Kwon OJ
- KMID: 2318415
- Tuberc Respir Dis.
- 2003 Apr;54(4):429-438.
BACKGROUND: The mortality from acute respiratory distress syndrome(ARDS) is > 40-50%. Although some prospective trials have failed to demonstrate a survival benefit of steroids in the early stages of ARDS,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Pilot Study of Bone Mineral Density in Men with Chronic Obstructive Pulmonary Disease
-
Bae YO, Han MS, Lee SK, Kim JN, Kim JS, Kim J, Cho Y, Lee YD
- KMID: 2318412
- Tuberc Respir Dis.
- 2003 Apr;54(4):395-402.
BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) are at increased risk for osteoporosis, which has implications for mobility and even mortality. The goal of this pilot study was to... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Dexamethasone on Gene Expression of Surfactant Protein B and Surfactant Protein C
-
Park IS, Sohn JW, Yoon HJ, Shin DH, Park SS
- KMID: 2318416
- Tuberc Respir Dis.
- 2003 Apr;54(4):439-448.
BACKGROUND: Surfactant protein B(SP-B) and surfactant protein C(SP-C) are important in accelerating surface spreading of surfactant phospholipid. The glucocorticoids accelerate the morphologic differentiation of epithelial cells into type II cells... -
- CITED
-
- Close
- SHARE
-
- Close
- The Mechanism of Proteasome Inhibitor-Induced Apoptosis in Lung Cancer Cells
-
Kim CH, Lee KH, Lee CT, Kim YW, Han SK, Shim YS, Yoo CG
- KMID: 2318413
- Tuberc Respir Dis.
- 2003 Apr;54(4):403-414.
BACKGROUND: Proteasome inhibitors can promote either cell survival or programmed cell death, depending on both the specific type and proliferative status of the cell. However, it is not well known... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Response to Etoposide Plus Carboplatin and Topotecan Chemotherapy in Small Cell Lung Cancer
-
Park KH, Cho GJ, Ju JY, Son CY, Wi JO, Kim KS, Kim YI, Lim SC, Kim YC, Park KO
- KMID: 2318414
- Tuberc Respir Dis.
- 2003 Apr;54(4):415-428.
BACKGROUND: This study assessed the efficacy and toxicity of etoposide and carboplatin(EC) combination regimen as a first line therapy for small cell lung cancer(SCLC), and determined the efficacy and toxicity... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of Combined Bronchial Asthma with COPD in Patients with Moderate to Severe Air flow Limitation
-
Rhee YK, In BH, Lee YD, Lee YC, Lee HB
- KMID: 2318411
- Tuberc Respir Dis.
- 2003 Apr;54(4):386-394.
BACKGROUND: ATS(American Thoracic Society) defined new guidelines for COPD(chronic obstructive lung disease) in April 2001, following the results of the global initiative for chronic obstructive lung disease. The most important... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of FK506 and Cyclosporin A on I(kappa)B(alpha) Degradation and IKK Pathway in Bronchial Epithelial Cells, Monocytes, Lymphocytes and Alveolar Macrophages
-
Yoon HI, Lee CH, Lee HS, Lee CT, Kim YW, Han SK, Shim YS, Yoo CG
- KMID: 2318417
- Tuberc Respir Dis.
- 2003 Apr;54(4):449-458.
BACKGROUND: Cyclosporin A(CsA) and tacrolimus(FK506) have been widely used as immunosuppressants. The effects of CsA, or FK506, on the IkappaB/NF-kappaB pathway have been shown to vary according to the cell... -
- CITED
-
- Close
- SHARE
-
- Close
